Abstract:Modulation of DNA base excision repair (BER) has the potential to enhance response to chemotherapy and improve outcomes in tumours such as melanoma and glioma. APE1, a critical protein in BER that processes potentially cytotoxic abasic sites (AP sites), is a promising new target in cancer. In the current study, we aimed to develop small molecule inhibitors of APE1 for cancer therapy. An industry-standard high throughput virtual screening strategy was adopted. The Sybyl8.0 (Tripos, St Louis, MO, USA) molecular modelling software suite was used to build inhibitor templates. Similarity searching strategies were then applied using ROCS 2.3 (Open Eye Scientific, Santa Fe, NM, USA) to extract pharmacophorically related subsets of compounds from a chemically diverse database of 2.6 million compounds. The compounds in these subsets were subjected to docking against the active site of the APE1 model, using the genetic algorithm-based programme GOLD2.7 (CCDC, Cambridge, UK). Predicted ligand poses were ranked on the basis of several scoring functions. The top virtual hits with promising pharmaceutical properties underwent detailed in vitro analyses using fluorescence-based APE1 cleavage assays and counter screened using endonuclease IV cleavage assays, fluorescence quenching assays and radiolabelled oligonucleotide assays. Biochemical APE1 inhibitors were then subjected to detailed cytotoxicity analyses. Several specific APE1 inhibitors were isolated by this approach. The IC50 for APE1 inhibition ranged between 30 nM and 50 μM. We demonstrated that APE1 inhibitors lead to accumulation of AP sites in genomic DNA and potentiated the cytotoxicity of alkylating agents in melanoma and glioma cell lines. Our study provides evidence that APE1 is an emerging drug target and could have therapeutic application in patients with melanoma and glioma.

Base Excision Repair in Mitotic Cells and the Role of Apurinic/Apyrimidinic Endonuclease 1 (APE1) in Post-Mitotic Transcriptional Reactivation of Genes

Molecular snapshots of APE1 proofreading mismatches and removing DNA damage

Functions of the major abasic endonuclease (APE1) in cell viability and genotoxin resistance

AP endonuclease 1: Biological updates and advances in activity analysis

Fine-tuning of DNA base excision/strand break repair via acetylation

Inner Amino Acid Contacts Are Key Factors of Multistage Structural Rearrangements of DNA and Affect Substrate Specificity of Apurinic/Apyrimidinic Endonuclease APE1

XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions.

A Novel Regulatory Circuit in Base Excision Repair Involving AP Endonuclease 1, Creb1 and DNA Polymerase Β

Isolation of a small molecule inhibitor of DNA base excision repair.

Development and Evaluation of Human AP Endonuclease Inhibitors in Melanoma and Glioma Cell Lines.

Regulation of Oxidized Base Damage Repair by Chromatin Assembly Factor 1 Subunit A

Nanoscale Interaction of Endonuclease APE1 with DNA

APURINIC/APYRIMIDINIC ENDONUCLEASE2 and ZINC FINGER DNA 3 '-PHOSPHOESTERASE Play Overlapping Roles in the Maintenance of Epigenome and Genome Stability

The chromatin remodeler ERCC6 and the histone chaperone NAP1 are involved in apurinic/apyrimidinic endonuclease-mediated DNA repair

Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1.

Cleavage of the APE1 N-Terminal Domain in Acute Myeloid Leukemia Cells Is Associated with Proteasomal Activity

Nucleolar accumulation of APE1 through condensates is mediated by rRNA forming G-quadruplex structures

Functional Importance and Divergence of Plant Apurinic/apyrimidinic Endonucleases in Somatic and Meiotic DNA Repair.

Impact of DNA ligase 1 and IIIα interactions with APE1 and polβ on the efficiency of base excision repair pathway at the downstream steps

Nanoscale interaction of endonuclease APE-1 with DNA characterized by atomic force microscopy

The Trajectory of Damaged-Base Eversion into the Active Site of Apurinic/Apyrimidinic Endonuclease APE1 Regulates This Enzyme's Substrate Specificity